MIAMI – March 5, 2025 – PharmaForceIQ is pleased to announce that executive Hemal Somaiya has been selected by MM+M as an honoree in the 2025 Women of Distinction program. Now in it’s 10th year, this program, presented jointly with the Women to Watch program, celebrates women leaders in pharma marketing who have significantly impacted their organizations and the broader industry.
Hemal is currently the Chief Strategy Officer at PharmaForceIQ. The technology company is building an omnichannel orchestration platform to engage the right customers with the right message on the right channel at the right time. She has been recognized for her achievements as a marketing leader in the pharmaceutical industry for more than 15 years.
“I’m honored to be selected as part of this amazing 2025 class of women who are creating waves in healthcare marketing,” said Hemal Somaiya. “I’m proud to build on my experience in this industry and collaborate so closely with PharmaForceIQ clients to educate physicians and drive better patient outcomes more effectively.”
Hemal has extensive experience throughout the therapeutic product lifecycle, from launching blockbuster global brands to helping growing and mature brands navigate a variety of market pressures and achieve diverse strategic imperatives. That includes past marketing leadership roles at Merck, AstraZeneca, Boston Scientific, and other companies.
“As an insightful, innovative, and charismatic leader, Hemal’s creative and strategic approach is reshaping the future of pharma marketing,” said Stephen Onikoro, Chief Operating Officer at PharmaForceIQ. “We’re thrilled to see Hemal receive such a well-deserved recognition for her outsized impact on our industry.”
“Medical marketing stands out as an industry where women are leading the charge,” said Lecia Bushak, Editor of Pharma at MM+M. “For the 10th year in a row, we’ve been highlighting the extraordinary work of women leaders who are driving creativity and innovation in the industry, as well as shaping the future of healthcare. We look forward to celebrating the accomplishments of the 2025 classes of Women of Distinction and Women to Watch.”
These women leaders in pharma marketing will be celebrated at an in-person event scheduled for June 3 in New York City and highlighted in the July-August print edition of MM+M.
Visit the MM+M website here to see the full list of honorees.
About PharmaForceIQ
PharmaForceIQ is the fastest growing independent provider of precision omnichannel marketing solutions for the Life Science industry. The company uses a proprietary set of machine learning technologies. Unique data solutions connect the dots, end-to-end, in the pharma marketing ecosystem offering real time omnichannel deployment in a way which prioritizes privacy and compliance, while also generating a clear return on investment for clients. Visit www.pharmaforceiq.com.
